Takeda, U.K. college explore stem cell therapy for muscular dystrophy

03/10/2014 | Genetic Engineering & Biotechnology News

Takeda will work with University College London to study the potential of induced pluripotent stem cells in the treatment of patients with muscular dystrophy. The $250,000 fund from Takeda's New Frontier Science group will also be used to explore new muscular dystrophy treatments through gene and cell therapy techniques using novel biomaterials and artificial human chromosomes.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA